The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
beigene | 260 |
belgene | 2 |
beigene, ltd. mourant ozannes corp… 🛈 | 2 |
beigene switzerland | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
fused tricyclic compounds as raf kinase inhibitors | 46 | 2011 |
fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors | 45 | 2011 |
fused heterocyclic compounds as protein kinase inhibitors | 38 | 2013 |
anti-pd1 antibodies and their use as therapeutics and diagnostics | 30 | 2013 |
fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors | 27 | 2011 |
fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors | 26 | 2013 |
substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones | 21 | 2013 |
maleate salts of a b-raf kinase inhibitor, crystalline forms, methods of preparation, an… 🛈 | 15 | 2015 |
fused tricyclic amide compounds as multiple kinase inhibitors | 12 | 2013 |
process for preparing parp inhibitor, crystalline forms, and uses thereof | 11 | 2015 |